Richter ' s Esmya Drug May Have Contributed to Liver Damage Cases-EMA Richter ' s Esmya Drug May Have Contributed to Liver Damage Cases-EMA

Hungarian drugmaker Richter ' s drug Esmya (ulipristal acetate) used to treat benign tumors of the womb may have contributed to some cases of serious liver damage, European health regulators said on Friday after a months-long review.Reuters Health Information
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news